Neurogene Inc. (NASDAQ: NGNE)
$39.8850
-0.1150 ( -0.29% ) 0.0K
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.
Market Data
Open
$39.8850
Previous close
$40.0000
Volume
0.0K
Market cap
$593.15M
Day range
$39.7850 - $39.7850
52 week range
$12.4900 - $74.4900
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Jan 18, 2024 |
| 4 | Insider transactions | 1 | Jan 18, 2024 |
| 4 | Insider transactions | 1 | Jan 18, 2024 |
| 4 | Insider transactions | 2 | Jan 18, 2024 |
| 4 | Insider transactions | 1 | Jan 18, 2024 |
| 4 | Insider transactions | 2 | Jan 18, 2024 |
| 8-k | 8K-related | 49 | Jan 05, 2024 |
| 3 | Insider transactions | 2 | Dec 26, 2023 |
| 3 | Insider transactions | 2 | Dec 26, 2023 |
| 3 | Insider transactions | 2 | Dec 26, 2023 |